Publisher
Springer International Publishing
Reference105 articles.
1. Ferro, V., Hammond, E., & Fairweather, J. K. (2004). The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini Reviews in Medicinal Chemistry, 4, 693–702.
2. Hammond, E., Bytheway, I., & Ferro, V. (2006). Heparanase as a target for anticancer therapeutics: New developments and future prospects. In M. Delehedde & H. Lortat-Jacob (Eds.), New developments in therapeutic glycomics (pp. 251–282). Trivandrum: Research Signpost.
3. Miao, H. Q., Liu, H., Navarro, E., Kussie, P., & Zhu, Z. (2006). Development of heparanase inhibitors for anti-cancer therapy. Current Medicinal Chemistry, 13, 2101–2111.
4. McKenzie, E. A. (2007). Heparanase: A target for drug discovery in cancer and inflammation. British Journal of Pharmacology, 151, 1–14.
5. Jia, L., & Ma, S. (2016). Recent advances in the discovery of heparanase inhibitors as anti-cancer agents. European Journal of Medicinal Chemistry, 121, 209–220.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献